Últimas actualizaciones

Brus­sels, 29 April 2026 – Cos­me­tics Euro­pe and the Inter­na­tio­nal Fra­gran­ce Asso­cia­tion wel­co­me the swift adop­tion of the Euro­pean Parliament’s report on Omni­bus VI at today’s ple­nary ses­sion in Stras­bourg. Over recent months, the Euro­pean Par­lia­ment has tho­roughly exa­mi­ned the Euro­pean Commission’s pro­po­sal to redu­ce admi­nis­tra­ti­ve bur­dens, and boost com­pe­ti­ti­ve­ness, with detai­led scru­tiny of the con­su­mer safety pro­vi­sions, which remain robust.

In early April, IFRA met with the Ger­man Fede­ral Ministry for Eco­no­mic Coope­ra­tion and Deve­lop­ment (BMZ) and the Ger­man Agency for Inter­na­tio­nal Coope­ra­tion (GIZ) to review one of its long-term sus­tai­na­bi­lity pro­jects, cen­tred on Buchu.

Brus­sels, 15 April 2026 – The Omni­bus VI pro­po­sal upda­ting the rules for cos­me­tic pro­ducts has taken a key step, with Mem­bers of the Euro­pean Par­lia­ment agreeing today on a way for­ward. The chan­ges voted on by the Euro­pean Parliament’s com­mit­tees uphold the highest safety stan­dards for con­su­mer cos­me­tic pro­ducts whilst aiming to redu­ce admi­nis­tra­ti­ve bur­dens and boost competitiveness.

The Inter­na­tio­nal Fra­gran­ce Asso­cia­tion (IFRA) was plea­sed to par­ti­ci­pa­te in Paris Per­fu­me Week, orga­ni­sed by Nez, le mou­ve­ment cul­tu­rel olfac­tif, joi­ning a panel dis­cus­sion dedi­ca­ted to the key regu­la­tory cha­llen­ges sha­ping the fra­gran­ce sec­tor in Europe.

In March, IFRA’s Vice-Pre­si­dent also joi­ned SAAFFI’s Annual Seminar.

Access and Bene­fit Sha­ring under the Nago­ya Pro­to­col remains a key prio­rity for IFRA. This work is sup­por­ted through a dedi­ca­ted joint Task For­ce with IOFI, focu­sed on prac­ti­cal imple­men­ta­tion and sec­tor-wide approaches.

Bel­gium has added ter­pinyl ace­ta­te mul­ti to the EU Registry of Inten­tions, sig­na­lling plans to sub­mit a har­mo­ni­sed clas­si­fi­ca­tion and labe­lling (CLH) dos­sier for the subs­tan­ce by 31 Decem­ber 2027.

Brus­sels, 24 March 2026 – In recent months, Euro­pean con­su­mers and policy­ma­kers have been increa­singly expo­sed to mis­lea­ding and inac­cu­ra­te claims regar­ding the safety of cos­me­tic and fra­gran­ce pro­ducts and their futu­re regu­la­tion. The­se inclu­de asser­tions that the Omni­bus VI revi­sion would relax safety rules for car­ci­no­ge­nic subs­tan­ces, lower safety stan­dards through regu­la­tory sim­pli­fi­ca­tion, or that cos­me­tic pro­ducts pose sig­ni­fi­cant health risks. Such claims are unfoun­ded. Their gro­wing volu­me risks under­mi­ning infor­med policy­ma­king and public trust.

Fran­ce has announ­ced on the Euro­pean Che­mi­cals Agency (ECHA) Registry of Inten­tions its plan to sub­mit a CLH dos­sier for ter­pi­neol (EC/​List No. 701−188−3; no CAS num­ber pro­vi­ded) by 31 Decem­ber 2026:

The EU ​“One Subs­tan­ce One Assess­ment” (OSOA) pac­ka­ge was published in the Offi­cial Jour­nal on 12 Decem­ber 2025 and ente­red into for­ce on 1 January 2026.

A visit to IFRA mem­ber com­pany IFF’s Til­burg site high­ligh­ted how inno­va­tion, sus­tai­na­bi­lity, and EU che­mi­cals policy con­nect on the fac­tory floor. The dis­cus­sions focu­sed on the prac­ti­cal impact of Omni­bus VI on Europe’s fra­gran­ce industry and competitiveness.